Cisplatin-selected resistance is associated with increased motility and stem-like properties via activation of STAT3/Snail axis in atypical teratoid/rhabdoid tumor cells
about
Cancer Stem Cell Plasticity Drives Therapeutic ResistanceEMT, CTCs and CSCs in tumor relapse and drug-resistanceSOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α SignalingMesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin.STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell.PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.Inhibition of STAT3 with the Generation 2.5 Antisense Oligonucleotide, AZD9150, Decreases Neuroblastoma Tumorigenicity and Increases Chemosensitivity.Low-dose DNA-demethylating agent enhances the chemosensitivity of cancer cells by targeting cancer stem cells via the upregulation of microRNA-497.Approaches for targeting cancer stem cells drug resistance.The relationship between platinum drug resistance and epithelial-mesenchymal transition.STAT3 but Not HIF-1α Is Important in Mediating Hypoxia-Induced Chemoresistance in MDA-MB-231, a Triple Negative Breast Cancer Cell Line.STAT3, stem cells, cancer stem cells and p63.Identification of genes and pathways associated with MDR in MCF-7/MDR breast cancer cells by RNA-seq analysis.Cancer Stem Cells are Regulated by STAT3 Signalling in Wilms Tumour.
P2860
Q26770274-4A59217F-D370-4DF5-AD15-E0B90BAC36AAQ28082935-9E82C44D-54B4-4EA3-9076-5309027455F8Q36184138-069EDA58-D99C-4CA6-951B-14D9E161DA6FQ36500869-F2EA0940-8291-4A7D-BE4F-10A4B61B79ABQ36561640-4B75DB24-0D91-49D7-BE78-0265C27B31CFQ37022200-58C20888-D2C5-49FA-B7AA-9214FB3E58A0Q37301868-C4993B2E-B1EF-49F9-A037-01C67396E1F5Q37615676-6F325C34-6FF9-4E8D-8829-8936F35AAD78Q37702541-664B041C-EABD-4E0B-BD61-4AACC8C39A43Q38734933-30CC3087-48AE-4967-A7B0-65035AB3DECAQ38778505-CA59DDD5-6BD8-4959-80D8-14770A291AC7Q38971795-4C1DFA04-A116-4556-8F45-938758DD4BBDQ39061847-C42BDEE3-A352-4B43-97E8-EDF827FA31C9Q43499055-DE4D273C-BD47-48F8-A1FD-C2B3088D626CQ52339863-69DF050A-23D3-429D-9288-16066CC03A75Q52669994-06484ECE-90AA-44D6-ABA3-86705A080413Q55254109-9EEE3717-AAFC-42DE-A174-88A2E1790686
P2860
Cisplatin-selected resistance is associated with increased motility and stem-like properties via activation of STAT3/Snail axis in atypical teratoid/rhabdoid tumor cells
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Cisplatin-selected resistance ...... teratoid/rhabdoid tumor cells
@ast
Cisplatin-selected resistance ...... teratoid/rhabdoid tumor cells
@en
type
label
Cisplatin-selected resistance ...... teratoid/rhabdoid tumor cells
@ast
Cisplatin-selected resistance ...... teratoid/rhabdoid tumor cells
@en
prefLabel
Cisplatin-selected resistance ...... teratoid/rhabdoid tumor cells
@ast
Cisplatin-selected resistance ...... teratoid/rhabdoid tumor cells
@en
P2093
P2860
P356
P1433
P1476
Cisplatin-selected resistance ...... teratoid/rhabdoid tumor cells
@en
P2093
Chian-Shiu Chien
Guang-Yuh Chiou
Ming-Chao Huang
Ming-Teh Chen
Mong-Lien Wang
Pin-I Huang
Shih-Hwa Chiou
Wei-Hsiu Liu
Yang-Hsin Shih
P2860
P304
P356
10.18632/ONCOTARGET.2737
P407
P577
2015-01-01T00:00:00Z